ContractProducts - Purchase Agreement • March 27th, 2023
NANCE PRECAST CONCRETE PRODUCTS - PURCHASE AGREEMENT EFFECTIVE DATE: The effective dated of this Purchase Agreement is November 1, 2011. PAYMENT TERMS: Net 30 with approved credit, otherwise COD, unless particular project terms have been established. Prices are subject to all applicable Federal, State, and Local Sales Taxes. If exempt, exemption certificate must be furnished. Prices are subject to change without notice prior to delivery. JOB CHANGES: Customer agrees to notify Nance Precast Concrete Products immediately of any structure changes in writing. In the event structures have been produced, Nance Precast Concrete Products agrees to rebuild the structures, as per the changes at the customer's expense. Customer agrees to pay for the structures already produced prior to notification of any changes. DELIVERY: Projects are quoted to include delivery to the jobsite based on full truc
AMENDED AND RESTATED PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • November 14th, 2023 • Rockwell Medical, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED PRODUCTS PURCHASE AGREEMENT (this "Agreement"), is entered into and effective as of the 18th day of September, 2023 (the "Effective Date"), by and between Rockwell Medical, Inc., a Delaware corporation ("Rockwell"), and DaVita Inc., a Delaware corporation ("DaVita") on behalf of itself and for the benefit of the DaVita Facilities (as defined in Recital B). Capitalized terms used herein and not otherwise defined herein shall have the meaning set forth in Article XVIII.
FIRST AMENDED AND RESTATED PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • August 1st, 2013 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
Healthcare Products Purchase AgreementProducts Purchase Agreement • June 29th, 2018 • China YCT International Group, Inc. • Pharmaceutical preparations
FIRST AMENDMENT TO FIRST AMENDED AND RESTATED PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • March 18th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus
This First Amendment to First Amended and Restated Products Purchase Agreement (the “First Amendment”) is entered into as of the 1st day of January, 2019 (“First Amendment Effective Date”) by and between DaVita Inc. (fka DaVita Healthcare Partners Inc.), a Delaware corporation having a principal place of business at 2000 16th Street, Denver, Colorado 80202 (“DaVita”) and Rockwell Medical, Inc., a Michigan corporation with a principal place of business at 30142 Wixom Road, Wixom, Michigan 48383 (“Rockwell”) (each a “Party” and collectively, the “Parties”).
SECOND AMENDMENT TO FIRST AMENDED AND RESTATED PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • March 18th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus
This Second Amendment to First Amended and Restated Products Purchase Agreement (the “Second Amendment”) is entered into as of the 1st day of February, 2019 (“Second Amendment Effective Date”) by and between DaVita Inc. (fka DaVita Healthcare Partners Inc.), a Delaware corporation having a principal place of business at 2000 16th Street, Denver, Colorado 80202 (“DaVita”) and Rockwell Medical, Inc., a Michigan corporation with a principal place of business at 30142 Wixom Road, Wixom, Michigan 48383 (“Rockwell”) (each a “Party” and collectively, the “Parties”).
= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. AMENDMENT ONE TO PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • May 16th, 2022 • Rockwell Medical, Inc. • Pharmaceutical preparations
This Amendment One (“Amendment”) to Products Purchase Agreement is by and between Rockwell Medical, Inc., a Delaware corporation (“Rockwell”), and DaVita Inc., f/k/a DaVita Healthcare Partners Inc., a Delaware corporation (“DaVita”) on behalf of itself and for the benefit of the DaVita Facilities (collectively the “Parties”), and is entered into as of April 6, 2022 (the “Amendment Effective Date”) amends the Products Purchase Agreement dated as of July 1, 2019 by and between the Parties (the “Agreement”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Agreement.
ContractProducts Purchase Agreement • November 8th, 2017
Hong Kong Exchange and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
ContractProducts Purchase Agreement • August 31st, 2020
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
ContractProducts Purchase Agreement • March 1st, 2019
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • March 7th, 2011 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • Delaware
THIS STOCK PURCHASE WARRANT (“Warrant”) CERTIFIES THAT, for value received, subject to the provisions hereinafter set forth, DaVita Inc. (the “Holder”) is entitled to purchase from Rockwell Medical Technologies, Inc., a Michigan corporation, and its successors and assigns (the “Company”) up to 100,000 shares (the “Warrant Shares”) of common stock of the Company, no par value (the “Common Stock”). This Warrant is the “Warrant Agreement” issued in accordance with that certain Products Purchase Agreement, dated as of February 16, 2011, between the Company and Holder (the “Agreement”). This Warrant is subject to the provisions and adjustments, and exercise hereof is subject to and will be made on the terms and conditions, hereinafter set forth.
EX-4.8 LOCAL MULTI POINT DISTRIBUTION SYSTEM (LMDS) PRODUCTS PURCHASE AGREEMENT NUMBER 99-001 TABLE OF CONTENTSProducts Purchase Agreement • October 26th, 1999 • First Florida Communications Inc • Cable & other pay television services
APPLICATION & CERTIFICATION CITRUS BY-PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • July 10th, 2012
Our firm, which is engaged in the manufacture of citrus products, hereby requests that the Texas Valley Citrus Committee (the “Committee”) approve this application for eligibility under sections 906.34 and 906.40 of Marketing Order No. 906.
PRODUCTS PURCHASE AGREEMENTProducts Purchase Agreement • May 27th, 2011 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • Delaware
GENERAL GUIDELINES APPLICABLE TO ALL PRODUCTS (DRI-SATE® DRY ACID CONCENTRATE, RENALPURE® LIQUID ACID CONCENTRATE, RENALPURE® BICARBONATE POWDER, STERILYTE® LIQUID BICARBONATE, CITRAPURE® DRY ACID and LIQUID ACID CONCENTRATE and CLEANING AGENTS)
